Delivery Order SPE2DB24D2205-SPE2DB24FDVYS

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,138.25 to provide COMBIPATCH 0.05-0.14 MG PTCH 8S, a pharmaceutical product. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,512.90, is a delivery order with a firm fixed price pricing type. It covers the procurement of COMBIPATCH 0.05-0.14 MG PTCH 8S medical supplies, with an ultimate completion date of February 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.80 firm fixed-price delivery order contract is for the provision of COMBIPATCH 0.05-0.14 MG PTCH 8S, a medical product. The contract has an ultimate completion date of August 28, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,045.24 firm fixed price delivery order is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a pharmaceutical product, with a performance period ending on March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,364.38, is a Delivery Order for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S medical products. The contract has an ultimate completion date of March 28, 2025 and is a Firm Fixed Price contract. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S medical patches. The contract has a firm fixed price of $2,975.82 and a completion date of September 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, was awarded this delivery order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,112.86 firm-fixed-price contract is for the delivery of COMBIPATCH 0.05-0.14 MG PTCH 8S medical supplies. The award is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,082.40, is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of September 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide essential medical commodities to support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,471.44, is for the delivery of COMBIPATCH 0.05-0.14 MG PTCH 8S medical supplies. The award has an ultimate completion date of March 25, 2025. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.87, is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a medical product. The contract is a Firm Fixed Price delivery order with an ultimate completion date of October 21, 2024. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVYS
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a $2,550.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the federal government. This contract is for the provision of 4564984416 COMBIPATCH 0.05-0.14 MG PTCH 8S, a medical product, with an ultimate completion date of June 25, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This award does not have a set-aside designation.

Generated 9/23/24, 9:49 AM